[HTML][HTML] The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications
K Kuwahara - Pharmacology & therapeutics, 2021 - Elsevier
Natriuretic peptides, which are activated in heart failure, play an important cardioprotective
role. The most notable of the cardioprotective natriuretic peptides are atrial natriuretic …
role. The most notable of the cardioprotective natriuretic peptides are atrial natriuretic …
Neprilysin expression and functions in development, ageing and disease
NN Nalivaeva, IA Zhuravin, AJ Turner - Mechanisms of ageing and …, 2020 - Elsevier
Neprilysin (NEP) is an integral membrane-bound metallopeptidase with a wide spectrum of
substrates and physiological functions. It plays an important role in proteolytic processes in …
substrates and physiological functions. It plays an important role in proteolytic processes in …
Nocturnal hypertension: new technology and evidence
K Kario - Hypertension, 2018 - Am Heart Assoc
The definition of nocturnal hypertension is night-time BP≥ 120/70 mm Hg (> 110/65 mm Hg
by the new 2017ACC/AHA guidelines; Table 1). Clinic and morning home BP of< 130/80 …
by the new 2017ACC/AHA guidelines; Table 1). Clinic and morning home BP of< 130/80 …
Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: the HOPE Asia Network
Hypertension is an important public health issue because of its association with a number of
significant diseases and adverse outcomes. However, there are important ethnic differences …
significant diseases and adverse outcomes. However, there are important ethnic differences …
[HTML][HTML] Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study
H Rakugi, K Kario, M Yamaguchi, T Sasajima… - Hypertension …, 2022 - nature.com
This phase III study assessed the efficacy and safety of sacubitril/valsartan compared with
those of olmesartan in Japanese patients with essential hypertension. Patients (n= 1161 …
those of olmesartan in Japanese patients with essential hypertension. Patients (n= 1161 …
Nocturnal hypertension and heart failure: mechanisms, evidence, and new treatments
K Kario, B Williams - Hypertension, 2021 - Am Heart Assoc
Heart failure (HF) is a common condition with an increasing prevalence. Despite a variety of
evidence-based treatments for patients with HF with reduced ejection fraction, morbidity and …
evidence-based treatments for patients with HF with reduced ejection fraction, morbidity and …
Hypertension: Current trends and future perspectives
PG Hunter, FA Chapman… - British Journal of Clinical …, 2021 - Wiley Online Library
Hypertension is a significant and increasing global health issue. It is a leading cause of
cardiovascular disease and premature death worldwide due to its effects on end organs …
cardiovascular disease and premature death worldwide due to its effects on end organs …
Emerging drug classes and their potential use in hypertension
Despite the availability of multiple antihypertensive drugs targeting the different pathways
implicated in its pathophysiology, hypertension remains poorly controlled worldwide, and its …
implicated in its pathophysiology, hypertension remains poorly controlled worldwide, and its …
[图书][B] Essential manual of 24-hour blood pressure management: from morning to nocturnal hypertension
K Kario - 2022 - books.google.com
ESSENTIAL MANUAL OF 24-HOUR BLOOD PRESSURE MANAGEMENT Hypertension is
one of the greatest threats to human health. The World Health Organization (WHO) …
one of the greatest threats to human health. The World Health Organization (WHO) …
Angiotensin receptor–neprilysin inhibitors for hypertension—hemodynamic effects and relevance to hypertensive heart disease
K Kario, B Williams - Hypertension Research, 2022 - nature.com
Angiotensin receptor–neprilysin inhibitors have multiple beneficial effects on the
cardiovascular system. The angiotensin receptor–neprilysin inhibitor sacubitril/valsartan has …
cardiovascular system. The angiotensin receptor–neprilysin inhibitor sacubitril/valsartan has …